Traws Pharma, Inc. (TRAW) › Shareholders' EquityTraws Pharma, Inc. (TRAW) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: -$108.72M2011: -$138.42M2012: -$158.31M2013: $80.90M2014: $23.62M2015: $10.84M2016: $5.13M2017: -$10.86M2018: $5.39M2019: $11.57M2020: $6.17M2021: $46.12M2022: $28.31M2023: $10.67M2024: -$31.63M2025: -$629.0K-$629.0K2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$629.0K+98.0%2024-$31.63M-396.4%2023$10.67M-62.3%2022$28.31M-38.6%2021$46.12M+646.9%2020$6.17M-46.6%2019$11.57M+114.9%2018$5.39M+149.6%2017-$10.86M-311.8%2016$5.13M-52.7%2015$10.84M-54.1%2014$23.62M-70.8%2013$80.90M+151.1%2012-$158.31M-14.4%2011-$138.42M-27.3%2010-$108.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share